The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

The global molecular cytogenetics market size is calculated at USD 2.78 billion in 2025 and is expected to reach around USD 6 ...

Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

On Thursday, a faction of the Pakistan Federal Union of Journalists filed an identical petition before the IHC, challenging the amendments to Peca 2025. Petition argues amendments violate ...

After a phase 3 study showed a promising pCR rate with HLX11, the pertuzumab biosimilar’s BLA has been accepted for review by the FDA.

ISLAMABAD (Dunya News) - The Anchors Association has challenged the Prevention of Electronic Crimes Act (PECA) 2025 in the Islamabad High Court (IHC). Senior anchorpersons Hamid Mir, Nasim Zahra, ...

Pakistan Federal Union of Journalists (PFUJ) filed a lawsuit in the Islamabad High Court (IHC) on Thursday against the controversial Prevention of Electronic Crimes (Amendment) Act, 2025 (Peca law).

ISLAMABAD: The Pakistan Federal Union of Journalists (PFUJ), Thursday, filed a petition in the Islamabad High Court (IHC) against the controversial Prevention of Electronic Crimes (Amendment ...

The Pakistan Federal Union of Journalists (PFUJ) has filed a petition in the Islamabad High Court challenging the recent amendments to the country's cybercrime law, calling for them to be struck ...